Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2007
International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature
Stuart M Lichtman, Hans Wildiers, Etienne Chatelut, et al.
Leukemia & Lymphoma
|
February 7, 2013
Herpes zoster complicating bortezomib therapy of relapsed/refractory indolent B-cell and mantle cell lymphoma: an analysis of two phase II trials
Melhem Solh, Richard I Fisher, André Goy, et al.
Future Oncology (London, England)
|
June 19, 2018
Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA
Vicki A Morrison, Jill A Bell, Laurie Hamilton, et al.
Leukemia & Lymphoma
|
July 6, 2014
Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501)
Vicki A Morrison, Sin-Ho Jung, Jeffrey Johnson, et al.
Open Forum Infectious Diseases
|
May 5, 2017
Comparative Sensitivity of Transthoracic and Transesophageal Echocardiography in Diagnosis of Infective Endocarditis Among Veterans With <i>Staphylococcus aureus</i> Bacteremia
Poorani Sekar, James R Johnson, Joseph R Thurn, et al.
Journal of Geriatric Oncology
|
December 14, 2017
The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436)
Vicki A Morrison, Linda McCall, Hyman B Muss, et al.
Journal of Geriatric Oncology
|
May 21, 2016
Pragmatic study designs for older adults with cancer: Report from the U13 conference
Ryan D Nipp, Nengliang Aaron Yao, Lisa M Lowenstein, et al.
Leukemia & Lymphoma
|
August 18, 2012
The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)
Melhem Solh, Kanti R Rai, Bercedis L Peterson, et al.
Blood
|
October 24, 2002
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)
John C Byrd, Bercedis L Peterson, Vicki A Morrison, et al.
British Journal of Haematology
|
August 26, 2010
Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI)
Ranjana H Advani, Haiyan Chen, Thomas M Habermann, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2007
International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature
Stuart M Lichtman, Hans Wildiers, Etienne Chatelut, et al.
Leukemia & Lymphoma
|
February 7, 2013
Herpes zoster complicating bortezomib therapy of relapsed/refractory indolent B-cell and mantle cell lymphoma: an analysis of two phase II trials
Melhem Solh, Richard I Fisher, André Goy, et al.
Future Oncology (London, England)
|
June 19, 2018
Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA
Vicki A Morrison, Jill A Bell, Laurie Hamilton, et al.
Leukemia & Lymphoma
|
July 6, 2014
Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501)
Vicki A Morrison, Sin-Ho Jung, Jeffrey Johnson, et al.
Open Forum Infectious Diseases
|
May 5, 2017
Comparative Sensitivity of Transthoracic and Transesophageal Echocardiography in Diagnosis of Infective Endocarditis Among Veterans With <i>Staphylococcus aureus</i> Bacteremia
Poorani Sekar, James R Johnson, Joseph R Thurn, et al.
Journal of Geriatric Oncology
|
December 14, 2017
The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436)
Vicki A Morrison, Linda McCall, Hyman B Muss, et al.
Journal of Geriatric Oncology
|
May 21, 2016
Pragmatic study designs for older adults with cancer: Report from the U13 conference
Ryan D Nipp, Nengliang Aaron Yao, Lisa M Lowenstein, et al.
Leukemia & Lymphoma
|
August 18, 2012
The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)
Melhem Solh, Kanti R Rai, Bercedis L Peterson, et al.
Blood
|
October 24, 2002
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)
John C Byrd, Bercedis L Peterson, Vicki A Morrison, et al.
British Journal of Haematology
|
August 26, 2010
Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI)
Ranjana H Advani, Haiyan Chen, Thomas M Habermann, et al.
Page
of 9